High Blood Pressure & Kidney Disease - NIDDK
normal lung pressure :: Article Creator FDA Approves Merck's New Drug For A Rare Lung Disease Pulmonary arterial hyptertension disproportionately impacts women of color, though its ultimate cause is still a mystery. getty Nearly 40,000 Americans are known to suffer from pulmonary arterial hypertension (PAH), a disease that causes the blood vessels in their lungs to progressively shrink, increasing both blood pressure and the risk of heart failure. Around 500 to 1,000 new cases are diagnosed every year, with the average patient only surviving about five to seven years after being diagnosed. The vast majority of people with this disease are women, and they are disproportionately Black or Hispanic. On Tuesday, the Food and Drug Administration approved a new drug to treat this disease called sotatercept which was developed and being marketed by pharmaceutical giant Merck under the name Winrevair. This is the first new type of treatment ...